A Reassortant Bunyavirus Isolated from Acute Hemorrhagic Fever Cases in Kenya and Somalia  by Bowen, Michael D. et al.
Virology 291, 185–190 (2001)
doi:10.1006/viro.2001.1201, available online at http://www.idealibrary.com onRAPID COMMUNICATION
A Reassortant Bunyavirus Isolated from Acute Hemorrhagic
Fever Cases in Kenya and Somalia1
Michael D. Bowen,*,2 Sam G. Trappier,* Angela J. Sanchez,* Richard F. Meyer,*,2 Cynthia S. Goldsmith,†
Sherif R. Zaki,† Lee M. Dunster,‡ C. J. Peters,*,3 Thomas G. Ksiazek,* Stuart T. Nichol,*,4 and the RVF Task Force5
*Special Pathogens Branch and †Infectious Disease Pathology Activity, Division of Viral and Rickettsial Diseases, Centers for Disease Control
and Prevention, Atlanta, Georgia 30333; and ‡Kenya Medical Research Institute, Nairobi, Kenya
Received July 13, 2001; returned to author for revision July 31, 2001; accepted September 19, 2001
In late 1997 and early 1998, a large outbreak of hemorrhagic fever occurred in East Africa. Clinical samples were collected
in Kenya and southern Somalia, and 27 of 115 (23%) hemorrhagic fever patients tested showed evidence of acute infection
with Rift Valley fever (RVF) virus as determined by IgM detection, virus isolation, detection of virus RNA by reverse
transcription-polymerase chain reaction (RT-PCR), or immunohistochemistry. However, two patients (one from Kenya and the
other from Somalia) whose illness met the hemorrhagic fever case definition yielded virus isolates that were not RVF.
Electron microscopy suggested these two virus isolates were members of the family Bunyaviridae. RT-PCR primers were
designed to detect bunyavirus RNA in these samples. Regions of the S and L segments of the two isolates were successfully
amplified, and their nucleotide sequences exhibited nearly complete identity with Bunyamwera virus, a mosquito-borne virus
not previously associated with severe human disease. Unexpectedly, the virus M segment appeared to be reassorted, as the
sequences detected exhibited 32–33% nucleotide and 28% amino acid differences relative to the corresponding M segment
sequence of Bunyamwera virus. The association of this reassortant bunyavirus, proposed name Garissa virus, with severe
disease is supported by the detection of the virus RNA in acute-phase sera taken from 12 additional hemorrhagic fever cases
in the region.The family Bunyaviridae contains five genera, Bunya-
virus, Hantavirus, Nairovirus, Phlebovirus, and Tospovi-
rus (2). Each genus is subdivided into serogroups. Hem-
orrhagic fever viruses, which cause febrile illness with
hemorrhagic manifestations, have been described in the
Hantavirus, Nairovirus, and Phlebovirus genera. An ex-
ample of a bunyaviral hemorrhagic fever virus is Rift
Valley fever virus (RVF, Phlebovirus), a mosquito-borne
virus that causes hemorrhagic fever in humans and
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185highly lethal, febrile disease in livestock characterized by
hepatitis and abortion (3).
Viruses of the genus Bunyavirus are known to cause
human disease but have not been associated previously
with hemorrhagic fevers. The known clinical picture of
bunyavirus-associated disease includes nondescript fe-
brile illness, often with myalgia and arthralgia, and en-
cephalitis (4). Bunyamwera virus, the prototype member
of the Bunyaviridae family, which was first isolated from
mosquitoes collected in Uganda in 1943 (5), causes
febrile illness with headache, arthralgia, rash, and infre-
quent central nervous system involvement (6). Bunyam-
wera virus and 31 other bunyaviruses comprise the Bu-
nyamwera serogroup within the Bunyavirus genus (2).
Bunyaviruses are lipid-enveloped viruses with a ge-
nome that consists of three single-stranded RNA seg-
ments designated S (small), M (medium), and L (large)
(7), encoding the nucleocapsid protein and nonstructural
protein, the two envelope glycoproteins (G1 and G2), and
the viral polymerase, respectively. Genetic reassortment
occurs in nature and in the laboratory by exchange of
genomic segments between parental viruses sharing
close antigenic and genetic relationships, i.e., within the
same serogroup (8, 9). Genetic reassortment can pro-
foundly affect RNA virus pathogenicity. For example, re-
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virus with a segmented genome) can result in new pan-
demic strains as a result of antigenic shift (10).
From October 1997 to January 1998, exceptionally
heavy rains (60–100 times normal rainfall) caused severe
flooding in Kenya and Somalia (1). Heavy rains and
increased standing water have previously been linked to
emergences of mosquito-borne diseases such as RVF
(3). In December 1997, the Kenyan Ministry of Health and
World Health Organization (WHO) received reports of 478
deaths due to hemorrhagic fever in northeastern Kenya
and southern Somalia (1). The disease was character-
ized by acute onset of fever and headache, followed by
hemorrhage (gastrointestinal and/or mucosal bleeding).
High rates of spontaneous abortion and deaths from
hemorrhage among domestic animals were also re-
ported. Disease surveillance in the Garissa District,
North Eastern Province, Kenya, was coordinated by the
international RVF task force in December 1997 (1). Of 231
reported cases of unexplained, severe febrile illness, 115
met the case definition for hemorrhagic fever (fever with
mucosal or gastrointestinal bleeding). Of these 115 pa-
tients, only 27 (23%) had evidence of acute RVF virus
infection as determined by detection of IgM antibody,
infectious virus, or virus RNA (by RT-PCR) in serum sam-
ples, or by immunohistochemistry (11) performed on liver
specimens using an anti-RVF mouse hyperimmune as-
citic fluid (1).
In addition to the RVF virus activity detected, two virus
isolates, designated 9800535 and 9800521, were ob-
tained from samples from hemorrhagic fever cases in
Garissa, North Eastern Province, Kenya and Baardheere,
Somalia, respectively. The viruses produced cytopathic
effect in cultured Vero E6 cells 2 to 4 days after inocu-
lation and did not react with anti-RVF immune mouse
ascitic fluid by immunofluorescence assay. Electron mi-
croscopy of thin sections of infected cells revealed bu-
nyavirus-like particles within vesicles in the cytoplasm
and in the extracellular spaces (Fig. 1). Virions averaged
79 nm in diameter and consisted of a homogeneous core
enclosed within the viral envelope and surrounded by
surface projections. These findings are consistent with
the ultrastructural appearance of other members of the
family Bunyaviridae (12, 13), except that the average
observed virion size was about 20% smaller.
Amplicons were successfully obtained by RT-PCR, and
partial genomic sequences were determined for the L,
M, and S segments of both isolates. The viruses were
found to be virtually identical to one another despite their
different geographic origins. The L segment fragments
(582 nt) of the virus isolates differed by only a single
nucleotide substitution; the M segment fragments (539 nt
for 9800521, and 542 nt for 9800535) differed by only two
nucleotide substitutions and the S segment fragments
(515 nt for 9800521, and 525 nt for 9800535) by only onesubstitution (GenBank Accession Nos. AF398345–
AF398350).
The L segment fragment sequences of these isolates
displayed greater than 97% nucleotide identity and 99.5%
amino acid identity with those of Bunyamwera virus (14).
Likewise, the S segment fragment sequences of the two
isolates exhibited greater than 93% nucleotide and 100%
amino acid identity with those of Bunyamwera virus (15).
Unexpectedly, the M segment fragment sequences
shared only 67–68% nucleotide and 72% amino acid
identity with those of Bunyamwera virus (16). This
amount of diversity is much greater than would be ex-
pected among Bunyamwera virus variants, based on the
low level of diversity seen among variants of other Bu-
nyamwera serogroup viruses, e.g., Cache Valley virus
variants (see Fig. 2). This extent of difference is compa-
rable to that observed between Bunyamwera virus and
Germiston (67% nucleotide and 68% amino acid identity)
or Cache Valley (66% nucleotide and 73–74% amino acid
identity) viruses (17, 18), the only other Bunyamwera
serogroup viruses for which M segment sequence data
FIG. 1. Transmission electron micrograph of Garissa virus-infected
Vero E6 cells. Extracellular virus particles show a homogeneous, ribo-
nucleoprotein-containing core surrounded by the viral envelope, which
is covered with prominent spikes. Bar, 100 nm.are currently available. These data demonstrate that the
isolates represent strains of a reassortant bunyavirus,
187RAPID COMMUNICATIONwith the genomic M segment coming from an unidenti-
fied Bunyamwera serogroup virus. We propose the name
Garissa virus for this reassortant bunyavirus. The
Garissa virus M segment has closer sequence identity to
that of Cache Valley virus (72% nucleotide and 77%
amino acid identity) than Bunyamwera virus. In addition,
phylogenetic analysis of sequence differences suggests
that the Garissa virus M segment shares a common
ancestor with Cache Valley virus rather than with Buny-
amwera or Germiston viruses (Fig. 2).
Consistent with the molecular identification of these
viruses, results of enzyme-linked immunosorbent assays
(ELISAs) done at the same time showed that antigens
prepared from Garissa virus-infected cell lysates reacted
strongly with polyvalent “grouping” antisera (antisera
prepared against Bunyamwera serogroup bunyaviruses)
(Table 1). In addition, antiserum specific for Bunyamwera
FIG. 2. Phylogenetic relationship of the M RNA segments of Buny-
amwera group viruses relative to those of representative California
group and Simbu group viruses. Maximum-likelihood analysis of the
aligned sequences of a 544-nucleotide region of virus M segments was
performed using PAUP4.0b5 (Sinauer Associates Inc.). Viruses included
Garissa virus isolates 9800521 and 9800535 (GenBank Accession Nos.
AF398348 and AF398347, respectively), Bunyamwera virus (BLCMA),
Germiston (BLCMPOLY), Cache Valley virus (AF082576, AF186241–
AF186243), Trivittatus virus (AF123491), California encephalitis virus
(AF123483), Keystone virus (AF123489), Serra do Navio (AF123490),
Melao virus (U88057), South River virus (AF123488), Inkoo virus
(U88059-60), Jamestown Canyon (U88058, AF123487), Oropouche virus
(AF312381), and Jatobal virus (AF312380). The analysis resulted in a
2Ln likelihood of 6344.88883 with an estimated transition to transver-
sion ratio of 1.658680 and g shape of 0.483871.virus reacted strongly with infected whole cells by indi-
rect immunofluorescense assay (data not shown).Of 70 serum samples tested by using a nested PCR
assay, Garissa virus was detected in serum samples
from 14 hemorrhagic fever cases, including the two pa-
tients who yielded the isolates. The broad geographic
distribution of these cases is shown in Fig. 3. Of these 14
cases, 6 had serologic evidence of past RVF infection
(i.e., anti-RVF IgM and/or IgG) but were negative for RVF
virus by isolation or diagnostic RT-PCR. The other 8
cases exhibited no evidence of RVF infection; only
Garissa virus was detected. In addition, the proportion of
bunyavirus-positive cases was approximately equal (19%
vs 21%) in the RVF seropositive (32 cases) and RVF
seronegative (38 cases) groups, respectively, suggesting
that Garissa virus infection and associated hemorrhagic
fever disease in these cases were occurring indepen-
dent of RVF infection. From the same group of 70 sam-
ples, RVF virus was detected in 9 cases by PCR assay
and only one of these cases displayed serologic evi-
dence of past bunyavirus infection. These findings
strongly suggest that Garissa virus was an etiologic
TABLE 1
Reaction of ELISA Antigens from Virus Isolates 9800521 and
9800535 with NIAID or CDC Typing Fluids
Grouping fluids Result
NIAID Group A1 2
NIAID Polyvalent Anoph. A 2
NIAID Polyvalent B1 2
NIAID Group B Master 2
NIAID Group Bunyamwera 1
CDC Broad Bunyamwera 1
NIAID Polyvalent Bwamba 2
NIAID Group California 2
NIAID Polyvalent Congo 2
NIAID Group Kemerevo 2
NIAID Polyvalent Palyam 2
NIAID Group Phlebotomus 2
NIAID Polyvalent Quaranfil 2
NIAID Polyvalent 5 2
NIAID Group Simbu 2
NIAID Group Tacaribe 2
NIAID Group VSV 2
NIAID Polyvalent 1 2
NIAID Polyvalent 4 2
NIAID Polyvalent 7 2
NIAID Polyvalent 8 2
NIAID Polyvalent 9 2
NIAID Polyvalent 10 2
NIAID Polyvalent 12 2
CDC Yellow fever MAB 2
No antibody control 2
CDC Normal mouse ascitic fluid 2
CDC Normal monoclonal (SP1) ascites control 2
CDC Polyvalent Old World Arenavirus HMAF 2
CDC Polyvalent New World Arenavirus HMAF 2
CDC Polyvalent Ebola HMAF 2
CDC Marburg HMAF 2Note. 1, positive; 2, negative.
agic fe
188 RAPID COMMUNICATIONagent of hemorrhagic fever in the 1997–1998 outbreak.
As the hemorrhagic disease associated with these
cases is quite unlike the neurological disease known to
be associated with Bunyamwera virus infections, it is
possible that this property is associated with the reas-
sorted M segment present in Garissa virus. However,
one cannot discount the possibility that the altered phe-
notype maps to amino acid differences in the L segment
or regions of the S or L segments not sequenced in this
study. Studies with reassortant California serogroup bu-
nyaviruses have shown that the ability of La Crosse virus
to reach the central nervous system after peripheral
inoculation maps to its M segment (19). The study pre-
sented here represents the first evidence suggesting
that natural genetic reassortment among bunyaviruses
has produced a human pathogen with newly identified
disease properties.
Methods: Virus Isolation. Serum samples from human
hemorrhagic fever cases were inoculated into 25-cm2
cell culture flasks containing confluent monolayers of
Vero E6 cells maintained in Earle’s minimal essential
medium with Hanks’ salts, 2% fetal bovine serum, and
antibiotics. Cell cultures were observed daily for evi-
dence of cytopathic effect. When cytopathic effect was
FIG. 3. Geographic distribution of hemorrhobserved, cells were removed for indirect immunofluo-
rescence assay, and the cells and culture medium werefrozen at 270°C. Virus seed pools were prepared from
culture medium and cells were lysed by thawing of the
frozen flasks.
Electron Microscopy. Infected Vero E6 cells were
washed with 0.2 M phosphate buffer, fixed with 2.5%
glutaraldehyde, and then pelleted by centrifugation. Cell
pellets were postfixed in buffered osmium tetroxide,
stained with uranyl acetate, dehydrated, and embedded
in Epon substitute and Araldite resins (20). Thin sections
were stained with uranyl acetate and lead citrate and
viewed using a Philips EM410-LS transmission electron
microscope.
Indirect Immunofluorescence Assay. Virus-infected
cells were tested for the presence of RVF virus antigens
by indirect immunofluorescence assay essentially as de-
scribed previously (21), except that cells were incubated
with anti-RVF immune mouse ascitic fluid.
ELISA. Antigens to the unknown viruses were pre-
pared by detergent extraction of infected cells (21) and
tested against arbovirus grouping antisera (NIAID Re-
agent and Reference Repository, Rockville, MD) in an IgG
ELISA format (21).
ver cases associated with Garissa virus.IgG and IgM Detection in Patient Sera. Patient sera
were tested for antiviral IgG by using Garissa virus-
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described previously (21). IgM antibody titers were de-
termined by IgM antibody capture ELISA using Garissa
virus-infected cell slurry prepared as described previ-
ously (21).
Genetic Characterization. RNA was extracted from cul-
ture medium harvested from infected Vero E6 cells by
using TriPure reagent according to the manufacturer’s
instructions (Boehringer Mannheim Corp.). Oligonucleo-
tide primers were designed to target conserved regions
in the three genomic segments of California and Buny-
amwera serogroup bunyaviruses. S RNA primers were
as follows: BUNYA1 (59-GTCACAGTAGTGTACTCCAC-39)
and BUNYA2 (59-CTGACAGTAGTGTGCTCCAC-39); M
RNA primers M14C (59-CGGAATTCAGTAGTGTACTACC-
39) and M619R (59-GACATATG(CT)TGATTGAAGCAAG-
CATG-39) (22); L RNA primers M13CBUNL1C (59-TGTA-
AAACGACGGCCAGTAGTGTACTCCT-39) and BUNL605R
(59-AGTGAAGTCICCATGTGC-39). RT-PCR was carried out
using an Access RT-PCR kit (Promega) and a Perkin–
Elmer 9600 thermocycler. Each RT-PCR contained 13
AMV/Tfl reaction buffer; 1 mM primer BUNYA1 and 1 mM
primer BUNYA2, or 1 mM primer M14C and 1 mM primer
M619R, or 1 mM primer M13CBUNL1C and 1 mM primer
BUNL650R; 500 mM MgSO4; 200 mM dNTPs; 5 U AMV
reverse transcriptase; 5 U Tfl DNA polymerase; and 10%
of the RNA from a single RNA extraction. Reverse tran-
scription was carried out for 1 h at 42°C, and the reac-
tions were heated for 2 min at 94°C. The reactions were
then subjected to 40 cycles of a temperature profile
consisting of 94°C for 30 s, 42–50°C for 1 min, and 68°C
for 2 min, followed by a final extension of 68°C for 7 min.
Ten percent (5 ml) of each reaction was then electropho-
resed on a 1% agarose gel in Tris–borate–EDTA buffer.
After electrophoresis, the gel was stained with ethidium
bromide and PCR products were visualized by UV trans-
lumination to assess product yield. Products were not
obtained for the reaction using primers BUNYA1 and
BUNYA2, so second-round PCR was carried out using
primers BUNCAL1 [59-CATTTTCC(A/T)GGIAAC(A/C)G-
GAACA-39; I 5 inosine] and BUNCAL2 (59-CCCCTAC-
CACCCACCC-39). Each second-round reaction contained
13 PCR buffer with 150 mM MgCl2 (Boehringer Mann-
heim Corp.), 1 mM primer BUNCAL1, 1 mM primer BUN-
CAL2, 200 mM dNTPs, 5 U Taq polymerase (Boehringer
Mannheim Corp.), and 1 ml of the first-round reaction.
The reactions were then subjected to 40 cycles of a
temperature profile consisting of 95°C for 30 s, 42°C for
1 min, and 72°C for 2 min, followed by a final extension
of 72°C for 10 min. Product yield was assessed by
agarose gel electrophoresis, as described previously.
To obtain sequence data for each virus, the remaining
RT-PCR or PCR product was electrophoresed on a 1%
agarose gel in Tris–acetate–EDTA buffer. After being
stained with ethidium bromide, specific PCR productswere located by UV translumination, sliced from the gel,
and purified from gel slices using a Sephaglas Bandprep
kit (Pharmacia Biotech). Dye terminator cycle sequenc-
ing reactions were carried out using 5 to 50% of the
gel-purified product (depending on product yield), ABI
PRISM Dye Terminator Cycle Sequencing Ready Reac-
tion Kits with AmpliTaq DNA Polymerase FS (Applied
Biosystems), and 3.3 pM primer. Extension products
were purified using Centri-sep spin columns (Princeton
Separations) and sequenced on an ABI 377 automated
DNA sequencer (Applied Biosystems). Chromatograms
were analyzed using Sequencher 3.0 software (Gene
Codes). Sequences were obtained from both strands of
each RT-PCR product for verification. Sequences were
aligned with the corresponding sequences of Bunyam-
wera group viruses including Bunyamwera virus (14–16)
(S RNA, D00353; M RNA, M11852; L RNA, X14383), Ger-
miston virus (17) (M RNA, M21951), Cache Valley viruses
(18) (M RNA, AF186241, AF186242, AF186243, AF082576),
and additional California and Simbu group viruses (see
legend to Fig. 3) retrieved from the GenBank sequence
database. Alignments and sequence database searches
were performed using the GAP and FASTA programs,
respectively, of the Wisconsin Package Version 9.1 UNIX
(Genetics Computer Group). Phylogenetic analysis was
carried out using PAUP4.0b5 (Sinauer Associates Inc.,
Sunderland, MA).
Diagnostic Nested PCR. RNA was extracted from 100
ml of patient serum as described above except that RNA
was isolated from the aqueous layer by using an RNaid
kit (Bio 101, Inc., La Jolla, CA) instead of isopropanol
precipitation. RT-PCR was performed as described
above using primers specific for conserved regions of
the S RNA of Bunyamwera serogroup bunyaviruses,
BUNS274C [59-CTTAAC(C/T)TTGGGGGCTGGA-39] and
BUNS957R (59-CCCCIACCACCCACCC-39), and a temper-
ature profile consisting of 94°C for 30 s, 50°C for 1 min,
and 68°C for 2 min, followed by a final extension of 68°C
for 7 min. If no visible products were obtained in the
RT-PCR assay, second-round PCR was carried out using
primers BUNCAL1 and BUNS743R (59-CTIACGTTIGTTT-
TCTCTCCA-39). The target regions for these primers re-
sided totally within the amplified region of the RT-PCR
primers in a “nested” fashion. Second-round reactions
were prepared as described previously and subjected to
40 cycles of a temperature profile consisting of 95°C for
30 s, 50°C for 1 min, and 72°C for 2 min, followed by a
final extension of 72°C for 10 min. Product yield was
assessed by agarose gel electrophoresis, and products
were purified and sequenced as described previously.
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